X-ray-induced lymphomagenesis in Eμ-pim-1 transgenic mice: An investigation of the co-operating molecular events

Carcinogenesis

Volumn 19, Issue 5, 1998, Pages 847-853

  Van Der Houven Van Oordt, C W ^a   Schouten, T G ^a   Van Krieken, J H J M ^a   Van Dierendonck, J H J ^a   Van Der Eb, A J ^a   Breuer, M L ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; LYMPHOMA; MALE; NONHUMAN; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; SPLEEN; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; X IRRADIATION;

ANIMALS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE DELETION; LYMPHOMA; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASMS, RADIATION-INDUCED; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-PIM-1; THYMUS NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; WHOLE-BODY IRRADIATION;

EID: 0031818345     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.5.847     Document Type: Article

References (53)

1. Cuypers.H.T., Selten,G., Quint,W., Zijlstra,M., Maandag,E.R., Boelens,W., van Wezenbeek,P., Melief,C. and Berns,A. (1984) Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell, 37, 141-150.
2. Selten,G., Cuypers,H.T. and Berns,A. (1985) Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J., 4, 1793-1798.
3. Amson,R., Sigaux,F., Przedborski,S., Flandrin,G., Givol,D. and Telerman,A. (1989) The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc. Natl Acad. Sci. USA, 86, 8857-8861.
4. Meeker,T.C., Loeb,J., Ayres,M. and Sellers,W. (1990) The human Pim-1 gene is selectively transcribed in different hemato-lymphoid cell lines in spite of a G + C-rich housekeeping promoter. Mol. Cell. Biol., 10, 1680-1688.
5. von Lindern,M., van Agthoven,T., Hagemeijer,A., Adriaansen,H. and Grosveld,G. (1989) The human pim-1 gene is not directly activated by the translocation (6;9) in acute nonlymphocytic leukemia. Oncogene, 4, 75-79.
6. van Lohuizen,M., Verbeek.S., Krimpenfort,P., Domen,J., Saris,C., Radaszkiewicz,T. and Berns,A. (1989) Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell, 56, 673-682.
7. Verbeek,S., van Lohuizen,M., van der Valk,M., Domen,J., Kraal,G. and Berns,A. (1991) Mice bearing the Eμ-myc and Eμ-pim-1 transgenes develop pre-B-cell leukemia prenatally. Mol. Cell. Biol., 11, 1176-1179.
8. Saris,C.J., Domen,J. and Berns,A. (1991) The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG. EMBO J., 10, 655-664.
9. Breuer,M., Slebos,R., Verbeek,S., van Lohuizen,M., Wientjens,E. and Berns,A. (1989) Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature, 340, 61-63.
10. Breuer,M., Wientjens,E., Verbeek,S., Slebos,R. and Berns,A. (1991) Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras. Cancer Res., 51, 958-963.
11. Sørensen,I.K., Mortensen,A., Kristiansen,E., van Kreijl,C., Adamson,R.H. and Thorgeirsson,S.S. (1996) Short term carcinogenicity testing of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in Eμ-pim-1 transgenic mice. Carcinogenesis, 17, 2221-2227.
12. Kroese,E.D., Dortant,P.M., van Steeg,H. et al. 1997) Use of Eμ-pim-1 transgenic mice for short term in vivo carcinogenicity testing: lymphoma induction by benzo[a]pyrene, but not by TPA. Carcinogenesis, 18, 975-980.
13. Hutchinson,F. (1993) Molecular biology of mutagenesis of mammalian cells by ionizing radiation. Semin. Cancer. Biol., 4, 85-92.
14. Kaplan,H. and Brown,M.B (1952) A quantitative dose-response study of lymphoid-tumor development in irradiated C57 black mice. J. Int. Cancer Inst., 13, 185-208.
15. Alitalo,K., Koskinen,P., Makela,T.P., Saksela,K., Sistonen,L. and Winqvist,R. (1987) Myc oncogenes: activation and amplification. Biochim. Biophys. Acta, 907, 1-32.
16. Sasaki,M. (1982) Current status of cytogenetic studies in animal tumors with special reference to nonrandom chromosome changes. Cancer Genet. Cytogenet., 5, 153-172.
17. van Lohuizen,M., Breuer,M. and Berns,A. (1989) N-myc is frequently activated by proviral insertion in MuLV-induced T cell lymphomas. EMBO J., 8, 133-136.
18. Zörnig,M., Schmidt,T., Karsunky,H., Grzeschiczek,A. and Möröy,T. (1996) Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2. Oncogene, 12, 1789-1801.
19. van Lohuizen,M., Verbeek,S., Scheijen,B., Wientjens,E., van der Gulden,H. and Berns,A. (1991) Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging. Cell, 65, 737-752.
20. Jonkers,J., Korswagen,H.C., Acton,D., Breuer,M. and Berns,A. (1997) Activation of a novel proto oncogene, frat1, contributes to progression of mouse T cell lymphomas. EMBO J., 16, 441-450.
21. Habets,G.G., Scholtes,E.H., Zuydgeest,D., van der Kammen,R.A., Stam,J.C., Berns,A. and Collard,J.G. (1994) Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell, 77, 537-549.
22. Siebert,R., Willers,C.P. and Opalka,B. (1996) Role of the cyclin dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma. Leuk. Lymphoma., 23, 505-520.
23. INK4 genes in hematologic malignancies. Leuk. Lymphoma., 23, 235-245.
24. Santos,J., Perez de Castro,I., Herranz,M., Pellicer,A. and Fernandez Piqueras,J. (1996) Allelic losses on chromosome 4 suggest the existence of a candidate tumor suppressor gene region of about 0.6 cM in γ-radiation-induced mouse primary thymic lymphomas. Oncogene, 12, 669-676.
25. van Dierendonck,J.H., Keyzer,R., van de Velde,C.J. and Cornelisse,C.J. (1989) Subdivision of S-phase by analysis of nuclear 5-bromodeoxyuridine staining patterns. Cytometry, 10, 143-150.
26. Gavrieli,Y., Sherman,Y. and Ben Sasson,S.A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol., 119, 493-501.
27. Chomczynski,P. and Sacchi,N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
28. Vasmel,W.L., Radaszkiewicz,T., Miltenburg,A.M., Zijlstra,M. and Melief,C.J. (1987) Refinement and precision in the classification of murine lymphomas by genotyping with immunoglobulin and T cell receptor probes. Leukemia, 1, 155-162.
29. Kronenberg,M., Goverman,J., Haars,R., Malissen,M., Kraig,E., Phillips,L., Delovitch,T., Suciu Foca,N. and Hood,L. (1985) Rearrangement and transcription of the beta-chain genes of the T-cell antigen receptor in different types of murine lymphocytes. Nature, 313, 647-653.
30. Berns,A.J., Lai,M.H., Bosselman,R.A., McKennett,M.A., Bacheler,L.T., Fan,H., Maandag,E.C., van der Putten,H.V. and Verma,I.M. (1980) Molecular cloning of unintegrated and a portion of integrated moloney murine leukemia viral DNA in bacteriophage lambda. J. Virol., 36, 254-263.
31. Haines,D.S., Landers,J.E., Engle,L.J. and George,D.L. (1994) Physical and functional interaction between wild-type p53 and mdm2 proteins. Mol. Cell. Biol., 14, 1171-1178.
32. Shvarts,A., Steegenga,W.T., Riteco,N. et al. (1996) Mdmx, a novel p53 binding protein with some functional properties of mdm2. EMBO J., 15, 5349-5357.
33. Dodemont,H.J., Soriano,P., Quax,W.J., Ramaekers,F., Lenstra,J.A., Groenen,M.A., Bernardi,G. and Bloemendal,H. (1982) The genes coding for the cytoskeletal proteins actin and vimentin in warm-blooded vertebrates. EMBO J., 1, 167-171.
34. 1NK4b genes. Oncogene, 11, 635-645.
35. Pattengale,P.K. and Taylor,C.R. (1983) Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias. Am. J. Pathol., 113, 237-265.
36. Möröy,T., Grzeschiczek,A., Petzold,S. and Hartmann,K.U. (1993) Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice. Proc. Natl Acad. Sci. USA, 90, 10734-10738.
37. Domen,J., van der Lugt,N.M., Acton,D., Laird,P.W., Linders,K. and Berns,A. (1993) Pim-1 levels determine the size of early B lymphoid compartments in bone marrow. J. Exp. Med., 178, 1665-1673.
38. Domen,J., van der Lugt,N.M., Laird,P.W., Saris,C.J., Clarke,A.R., Hooper,M.L. and Berns,A. (1993) Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells. Blood, 82, 1445-1452.
39. Domen,J., van der Lugt,N.M., Laird,P.W., Saris,C.J. and Berns,A. (1993) Analysis of Pim-1 function in mutant mice. Leukemia, 7, S108-S112.
40. Bueso Ramos,C.E., Yang,Y., deLeon,E., McCown,P., Stass,S.A. and Albitar,M. (1993) The human MDM-2 oncogene is overexpressed in leukemias. Blood, 82, 2617-2623.
41. Bueso Ramos,C.E., Manshouri,T., Haidar,M.A., Huh,Y.O., Keating,M.J. and Albitar,M. (1995) Multiple patterns of MDM-2 deregulation in human leukemias: implications in leukemogenesis and prognosis. Leuk. Lymphoma, 17, 13-18.
42. Quesnel,B., Preudhomme,C., Philippe,N., Vanrumbeke,M., Dervite,I., Lai,J.L., Bauter, F., Wattel,E. and Fenaux,P. (1995) p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood, 85, 657-663.
43. Storer,R.D., Cartwright,M.E., Cook,W.O., Soper,K.A. and Nichols,W.W. (1995) Short-term carcinogenesis bioassay of genotoxic procarcinogens in PIM® transgenic mice. Carcinogenesis, 16, 285-293.
44. Gaufo,G.O. and Diamond,M.C. (1996) Prolactin increases CD4/CD8 cell ratio in thymus-grafted congenitally athymic nude mice. Proc. Natl Acad. Sci. USA, 93, 4165-4169.
45. Matera,L. (1996) Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci., 59, 599-614.
46. Mochizuki,T., Kitanaka,C., Noguchi,K., Sugiyama,A., Kagaya,S., Chi,S.J., Asai,A. and Kuchino,Y. (1997) Pim-1 kinase stimulates c-Myc-mediated death signaling upstream of caspase-3 (CPP32)-like protease activation. Oncogene, 15, 1471-1480.
47. van der Lugt,N.M., Domen,J., Verhoeven,E., Linders,K., van der Gulden,H., Allen,J. and Berns,A. (1995) Proviral tagging in Eμ-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2. EMBO J., 14, 2536-2544.
48. Haran Ghera,N. (1966) Leukemogenic activity of centrifugates from irradiated mouse thymus and bone marrow. Int. J. Cancer, 1, 81-87.
49. Warren,W., Clark,J.P., Gardner,E., Harris,G., Cooper,C.S. and Lawley,P.D. (1990) Chemical induction of thymomas in AKR mice: interaction of chemical carcinogens and endogenous murine leukemia viruses. Comparison of N-methyl-N-nitrosourea and methyl methanesulphonate. Mol. Carcinogenesis, 3, 126-133.
50. Brathwaite,O., Bayona,W. and Newcomb,E.W. (1992) p53 mutations in C57BL/6J murine thymic lymphomas induced by γ-irradiation and N-methylnitrosourea. Cancer Res., 52, 3791-3795.
51. Saez,G.T., Oliva,M.R., Mangues,R. and Pellice,A. (1994) Absence of MDM-2 gene amplification in experimentally induced tumors regardless of p53 status. Mol. Carcinogenesis, 9, 40-45.
52. ink4a alterations in murine primary T cell lymphomas. Oncogene, 14, 1361-1370.
53. Selten,G., Cuypers,H.T., Zijlstra,M., Melief,C. and Berns,A. (1984) Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation. EMBO J., 3, 3215-3222.